Two Sigma Advisers’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-186,880
Closed -$7.18M 2650
2023
Q2
$7.18M Sell
186,880
-28,000
-13% -$1.08M 0.02% 614
2023
Q1
$4.97M Sell
214,880
-22,100
-9% -$512K 0.01% 809
2022
Q4
$6.21M Sell
236,980
-8,200
-3% -$215K 0.02% 690
2022
Q3
$4.82M Buy
245,180
+110,700
+82% +$2.18M 0.01% 751
2022
Q2
$2.35M Sell
134,480
-4,040
-3% -$70.7K 0.01% 1132
2022
Q1
$2.27M Sell
138,520
-178,400
-56% -$2.92M 0.01% 1179
2021
Q4
$5.17M Sell
316,920
-62,800
-17% -$1.02M 0.01% 753
2021
Q3
$4.85M Buy
379,720
+215,800
+132% +$2.75M 0.01% 795
2021
Q2
$2.32M Buy
163,920
+74,500
+83% +$1.05M 0.01% 1223
2021
Q1
$1.39M Sell
89,420
-3,800
-4% -$59.1K ﹤0.01% 1461
2020
Q4
$1.48M Buy
93,220
+20,460
+28% +$324K ﹤0.01% 1403
2020
Q3
$884K Sell
72,760
-2,380
-3% -$28.9K ﹤0.01% 1555
2020
Q2
$868K Buy
75,140
+3,360
+5% +$38.8K ﹤0.01% 1646
2020
Q1
$983K Sell
71,780
-920
-1% -$12.6K ﹤0.01% 1498
2019
Q4
$429K Buy
72,700
+16,960
+30% +$100K ﹤0.01% 1934
2019
Q3
$295K Buy
55,740
+3,640
+7% +$19.3K ﹤0.01% 1926
2019
Q2
$401K Buy
52,100
+2,660
+5% +$20.5K ﹤0.01% 1899
2019
Q1
$984K Buy
49,440
+21,620
+78% +$430K ﹤0.01% 1537
2018
Q4
$367K Buy
27,820
+21,220
+322% +$280K ﹤0.01% 1895
2018
Q3
$243K Sell
6,600
-720
-10% -$26.5K ﹤0.01% 2024
2018
Q2
$256K Buy
+7,320
New +$256K ﹤0.01% 2146
2016
Q1
Sell
-1,720
Closed -$242K 2169
2015
Q4
$242K Buy
+1,720
New +$242K ﹤0.01% 1593